News
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas®
30 Sep 2024
Read More
Owlstone Medical Opens New High Volume Breath Biopsy Lab with Tony Blair Visit
Read More
17 Mar 2017
Owlstone Medical to provide Breath Biomarker Services for 4D Pharma using Breath Biopsy® platform
Read More
7 Mar 2017
You’ve heard of liquid biopsy, now get ready for breath biopsy – Billy Boyle interview with EP Vantage
Read More
28 Feb 2017
Owlstone Medical commences 1,400 patient clinical trial for early detection of colorectal cancer
Read More
7 Feb 2017
Owlstone Medical Announces $11.55M USD Fundraising
Read More
6 Jan 2017
Medtech Insight: “Owlstone Medical is leading the charge on breath analysis”
Read More
11 Dec 2016
Cambridge Business Interview with CEO Billy Boyle
Read More
10 Dec 2016
Owlstone Medical’s ReCIVA Named Invention of the Year in Top 50 Digital Health Awards
Read More
10 Dec 2016
Owlstone Medical Selected to Participate at Upcoming Cavendish Global Health Impact Forum
Read More
5 Dec 2016
Owlstone Medical and Imperial College collaborate to study underlying causes of asthma exacerbations
Read More
1 Nov 2016
Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer
Read More
4 Oct 2016
Owlstone Medical commences next phase in world’s largest breath-based clinical trial for early cancer detection
Read More
22 Sep 2016